Home Medicine Neonatal manifestations of maternal phencyclidine exposure
Article
Licensed
Unlicensed Requires Authentication

Neonatal manifestations of maternal phencyclidine exposure

  • Nancy L. Golden , Betty R. Kuhnert , Robert J. Sokol , Susan Martier and Thomas Williams
Published/Copyright: October 15, 2009
Journal of Perinatal Medicine
From the journal Volume 15 Issue 2

Published Online: 2009-10-15
Published in Print: 1987

Walter de Gruyter

Articles in the same Issue

  1. Titelei
  2. Review article
  3. Announcement
  4. A randomized study of two cups for vacuum extraction
  5. Heterogeneity of congenital primary hypothyroidism: The importance of thyroid scintigraphy
  6. 15-keto-13, 14-dihydroprostaglandin F2α and prolactin in maternal and cord blood during prostaglandin E2 or oxytocin therapy for labor induction
  7. Announcement
  8. Low Apgar score as a risk factor for respiratory disturbances in the newborn infant
  9. Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy
  10. The effect of placenta previa localization upon maternal and fetal-neonatal outcome
  11. Announcements
  12. Combined electronic fetal heart rate and fetal movement monitor — a preliminary report
  13. Neonatal manifestations of maternal phencyclidine exposure
  14. Morphometric investigations of terminal villi of diabetic placentas in relation to the White classification of diabetes mellitus
  15. Short communications
  16. Announcement
  17. Guidelines & Checklist
https://doi.org/10.1515/jpme.1987.15.2.185

Articles in the same Issue

  1. Titelei
  2. Review article
  3. Announcement
  4. A randomized study of two cups for vacuum extraction
  5. Heterogeneity of congenital primary hypothyroidism: The importance of thyroid scintigraphy
  6. 15-keto-13, 14-dihydroprostaglandin F2α and prolactin in maternal and cord blood during prostaglandin E2 or oxytocin therapy for labor induction
  7. Announcement
  8. Low Apgar score as a risk factor for respiratory disturbances in the newborn infant
  9. Preconceptional diabetes control in insulin-dependent diabetes mellitus patients with continuous subcutaneous insulin infusion therapy
  10. The effect of placenta previa localization upon maternal and fetal-neonatal outcome
  11. Announcements
  12. Combined electronic fetal heart rate and fetal movement monitor — a preliminary report
  13. Neonatal manifestations of maternal phencyclidine exposure
  14. Morphometric investigations of terminal villi of diabetic placentas in relation to the White classification of diabetes mellitus
  15. Short communications
  16. Announcement
  17. Guidelines & Checklist
Sign up now to receive a 20% welcome discount
Institutional Access
How does access work?
Have an idea on how to improve our website?
Please write us.
© 2025 De Gruyter Brill
Downloaded on 31.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpme.1987.15.2.185/html
Scroll to top button